Literature DB >> 15299186

Should mammographic screening be done in primary ovarian cancer?: A case control study in Turkish women.

M Ozguroglu1, B Avci, H Turna, G Esen, B Arun, V Celik, S Serdengeçti.   

Abstract

Breast cancer is a significant global health problem. It is the most common malignancy in women. Mammographic screening is recommended for women older than 40 yr for early detection of breast cancer. The aim of this study is to evaluate the role of screening mammography in ovarian cancer independent of age. Eighty-four patients with ovarian cancer were evaluated with bilateral mammography. Two hundred asymptomatic healthy controls with a similar age distribution were also imaged with screening mammography. Mammography results were classified according to the American College of Radiology criteria in five groups. The median age of the study group was 51.4 (range, 27-77) and 49.3 (range, 30-75) in the control group. Screening mammography detected four cases of malignancy (4.8%) in patients with ovarian cancer; two were the primary breast carcinomas(2.5%) and two were metastatic cancers from the ovary. Five subjects (2.5%) among healthy controls were also found to have breast cancer. Although the incidence of primary breast carcinoma was found to be similar in the two groups (2.5%), mammographic imaging detected metastatic disease to the breast from the ovaries. Mammography should therefore be considered in patients with ovarian cancer independent of age.

Entities:  

Mesh:

Year:  2004        PMID: 15299186     DOI: 10.1385/MO:21:2:139

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  7 in total

Review 1.  The benefits and risks of mammographic screening for breast cancer.

Authors:  S F Hurley; J M Kaldor
Journal:  Epidemiol Rev       Date:  1992       Impact factor: 6.222

2.  Carcinoma of the breast and ovary in three families.

Authors:  H T Lynch; A J Krush
Journal:  Surg Gynecol Obstet       Date:  1971-10

Review 3.  Molecular genetics of hereditary ovarian cancer.

Authors:  J Boyd
Journal:  Oncology (Williston Park)       Date:  1998-03       Impact factor: 2.990

4.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

5.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.

Authors:  A B Miller; C J Baines; T To; C Wall
Journal:  CMAJ       Date:  1992-11-15       Impact factor: 8.262

6.  Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; D T Bishop; S A Narod; D E Goldgar
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

7.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.